Clinical Trial Update: An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)

View source ↗

Summary

A real-world, post-authorization safety study evaluating the safety of tofacitinib in adults with moderately to severely active ulcerative colitis in the Europe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | Conditions: Ulcerative Colitis | Status: RECRUITING